Syndax Pharmaceuticals (SNDX) EBT Margin Growth (1y) (2016 - 2026)
Syndax Pharmaceuticals (SNDX) EBT Margin Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -153.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -571.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 452.00 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1,076.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -9,422.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -392.00 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1,911.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 29,565.00 |
| 10 | Syndax Pharmaceuticals | 1.77 Bn | 1.22 Bn | 60.67 Mn | 11,682.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10,062.00 |
| Mar 31, 2026 | 35,655.00 |
| Dec 31, 2025 | 117,619.00 |
| Sep 30, 2025 | 54,147.00 |
| Jun 30, 2025 | 194,599.00 |
| Dec 31, 2021 | 544,085.00 |
| Sep 30, 2021 | 519,265.00 |
| Jun 30, 2021 | -152,533.00 |
| Mar 31, 2021 | -323,799.00 |
| Dec 31, 2020 | -199,026.00 |
| Sep 30, 2020 | -156,966.00 |
| Jun 30, 2020 | -14,037.00 |
| Mar 31, 2020 | -15,383.00 |
| Dec 31, 2019 | 213,053.00 |
| Sep 30, 2019 | 91,372.00 |
| Jun 30, 2019 | 59,868.00 |
| Mar 31, 2019 | 135,251.00 |
| Dec 31, 2018 | -364,686.00 |
| Sep 30, 2018 | 36,929.00 |
| Jun 30, 2018 | -45,267.00 |